Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Exemestane|DRUG: Celecoxib|OTHER: Correlative studies
Sponsor: Ohio State University Comprehensive Cancer Center
Collaborators: Pfizer